JNJON

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue.

NumeJNJON

PozițieNo.3331

Capitalizare de piață$0.00

Capitalizare de piață complet diluată$0.00

Cotă de piață%

Volum de tranzacționare/capitalizare de piață (24 h)743,256.89%

Ofertă află în circulație128.5796356

Ofertă maximă0

Ofertă totală128.5796356

Rată de circulație%

Data emiterii--

Prețul la care activul a fost emis pentru prima dată--

Maxim dintotdeauna250.607309426007,2026-03-02

Cel mai mic preț203.9667432969526,2026-01-09

Lanț de blocuri publicETH

IntroducereJohnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue.

Sector

Rețele sociale

• Pagină de internet oficială
• Explorator de blocuri

etfindex:mc_etfindex_sourceDeclarație de declinare a responsabilității: Datele sunt furnizate de cmc și nu trebuie considerate drept consultanță pentru investiții.